[Extrahepatic manifestations of HCV infection]

Vnitrni Lekarstvi
|October 12, 2016
PubMed

Insights

Hepatitis C virus (HCV) infection frequently causes extrahepatic manifestations, most commonly mixed cryoglobulinemia. Direct-acting antivirals offer new treatment avenues for chronic hepatitis C and its associated conditions.

Area of Science:

  • Hepatology
  • Immunology
  • Virology

Background:

  • Extrahepatic manifestations are common in chronic Hepatitis C Virus (HCV) infection.
  • Mixed cryoglobulinemia, characterized by immune complex deposition, is the most frequent extrahepatic manifestation.
  • HCV RNA and anti-HCV antibodies are found in cryoprecipitates, alongside rheumatoid factor.

Purpose of the Study:

  • To review the established and probable extrahepatic manifestations of chronic HCV infection.
  • To highlight the role of mixed cryoglobulinemia and its pathogenesis.
  • To discuss the implications of direct-acting antivirals in managing HCV-related conditions.

Main Methods:

  • Literature review of studies on HCV extrahepatic manifestations.
  • Analysis of the composition and deposition of cryoglobulins.
  • Correlation of HCV infection with specific autoimmune and lymphoproliferative disorders.

Main Results:

  • Established links include membranoproliferative glomerulonephritis, vasculitis, B cell lymphoma, Sjögren syndrome, lichen planus, porphyria cutanea tarda, and diabetes mellitus.
  • Probable associations involve thyroid disease, arthralgias, fatigue, and autoimmune hepatitis.
  • Direct-acting antivirals represent a significant advancement in treating chronic HCV and its sequelae.

Conclusions:

  • Chronic HCV infection is associated with a wide spectrum of extrahepatic conditions, primarily driven by immune dysregulation and cryoglobulinemia.
  • Early diagnosis and treatment of HCV are crucial to prevent or manage these manifestations.
  • Emerging therapies like direct-acting antivirals hold promise for improving outcomes in patients with HCV-related extrahepatic diseases.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
309
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
723